1. |
Chugh SS,Havmoeller R,Narayanan K,et al.Worldwide epidemiology of atrial fibrillation:a Global Burden of Disease 2010 Study.Circulation,2014,129(8):837-847.
|
2. |
黄从新,张澍,马长生,等.心房颤动:目前的认识和治疗建议——2012.中华心律失常学杂志,2012,16(4):246-289.
|
3. |
Wu N,Xu B,Xiang Y,et al.Association of inflammatory factors with occurrence and recurrence of atrial fibrillation:a metaanalysis.Int J Cardiol,2013,169(1):62-72.
|
4. |
Ederhy S,Di Angelantonio E,Dufaitre G,et al.C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation.Int J Cardiol,2012,159(1):40-46.
|
5. |
Marcus GM,Whooley MA,Glidden DV,et al.Interleukin-6 and atrial fibrillation in patients with coronary artery disease:data from the Heart and Soul Study.Am Heart J,2008,155(2):303-309.
|
6. |
Kumagai K,Nakashima H,Saku K.The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model.Cardiovasc Res,2004,62(1):105-111.
|
7. |
Aviles RJ,Martin DO,Apperson-Hansen C,et al.Inflammation as a risk factor for atrial fibrillation.Circulation,2003,108(24):3006-3010.
|
8. |
Chung MK,Martin DO,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation.Circulation,2001,104(24):2886-2891.
|
9. |
Bruins P,Te VH,Yazdanbakhsh AP,et al.Activation of the complement system during and after cardiopulmonary bypass surgery:postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia.Circulation,1997,96(10):3542-3548.
|
10. |
Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation.Circulation,1997,96(4):1180-1184.
|
11. |
Tatemoto K,Hosoya M,Habata Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.Biochem Biophys Res Commun,1998,251(2):471-476.
|
12. |
Habchi M,Duvillard L,Cottet V,et al.Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control.Clin Endocrinol(Oxf),2014,81(5):696-701.
|
13. |
Przewlocka-Kosmala M,Kotwica T,Mysiak A,et al.Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction.J Hypertens,2011,29(5):971-979.
|
14. |
Kadoglou NP,Lampropoulos S,Kapelouzou A,et al.Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease——KOZANI STUDY.Transl Res,2010,155(5):238-246.
|
15. |
Pisarenko OI,Lankin VZ,Konovalova GG,et al.Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion.Mol Cell Biochem,2014,391(1-2):241-250.
|
16. |
Lim R,Barker G,Riley C,et al.Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells.Reprod Sci,2013,20(8):957-967.
|
17. |
Pan C S,Teng X,Zhang J,et al.Apelin antagonizes myocardial impairment in sepsis.J Card Fail,2010,16(7):609-617.
|
18. |
Visser YP,Walther FJ,Laghmani EH,et al.Apelin attenuates hyperoxic lung and heart injury in neonatal rats.Am J Respir Crit Care Med,2010,182(10):1239-1250.
|
19. |
Ellinor PT,Low AF,Macrae CA.Reduced apelin levels in lone atrial fibrillation.Eur Heart J,2006,27(2):222-226.
|
20. |
Falcone C,Buzzi MP,D'Angelo A,et al.Apelin plasma levels predict arrhythmia recurrence in patients with persistent atrial fibrillation.Int J Immunopathol Pharmacol,2010,23(3):917-925.
|
21. |
Ellinor PT,Low A,Patton KK,et al.C-Reactive protein in lone atrial fibrillation.Am J Cardiol,2006,97(9):1346-1350.
|